Sensitive ASX Announcement

Zelira Meets Primary Endpoints for Insomnia Trial

Published: 19/02/20, 09:53am (AEST)5 pages
Zelira Therapeutics Limited
ZLD:ASXHealthcare

Recent ZLD Announcements

Price Sensitive only